Skip to main content
. 2015 Sep 18;36(5):197–202. doi: 10.4082/kjfm.2015.36.5.197

Table 3. Assessment response to tyrosine kinase inhibitor therapy.

graphic file with name kjfm-36-197-i003.jpg

BCR, breakpoint cluster region; ABL, Abelson murine leukemia; mRNA, messenger ribonucleic acid.